Maven Income and Growth VCT 3 PLC Issue of Supplementary Prospectus (6537U)

TIDMMIG3 TIDMMIG1 TIDMMAV4 TIDMMIG5

RNS Number : 6537U

Maven Income and Growth VCT 3 PLC

29 March 2023

Joint Announcement

Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC, and Maven Income and Growth VCT 5 PLC (the "Companies")

Issue of Supplementary Prospectus

The Boards of the Companies today announce that they have published a supplementary prospectus (the "Supplementary Prospectus") relating to the offers for subscription issued by the Companies, details of which were set out in their prospectus (comprising a securities note, registration document and summary) issued on 7 October 2022.

The publication of the Supplementary Prospectus is a regulatory requirement under the Prospectus Regulation Rules and Section 87G of The Financial Services and Market Act 2000 following the publication by each of Maven Income and Growth VCT 3 PLC (on 14 March 2023) and Maven Income and Growth VCT 5 PLC (on 23 March 2023) of their respective Annual Report and Financial Statements for the year ended 30 November 2022.

The Supplementary Prospectus has been approved by the Financial Conduct Authority, and a copy will shortly be available for inspection at the National Storage Mechanism, which is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Copies of the Supplementary Prospectus are available free of charge from the office of the investment manager of the Companies, Maven Capital Partners UK LLP, at Kintyre House, 205 West George Street, Glasgow G2 2LW and from the website of Maven Capital Partners UK LLP at: www.mavencp.com/vctoffer.

Enquiries

For further information, please contact:

Maven Capital Partners UK LLP

Tel: [phone]

E-mail: [e-mail]

Maven Capital Partners UK LLP

Secretary

29 March 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PDISEFFDUEDSEFD

(END) Dow Jones Newswires

March 29, 2023 09:19 ET (13:19 GMT)